Botanix Pharmaceuticals Ltd has released a press release.
Presentation- FDA Letter Requires Patient Instruction Update
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Botanix Pharmaceuticals
- FDA Letter Requires Patient Instruction Update
- Response to ASX Price and Volume Query
- Appendix 4E Preliminary Final Report
- Appointment of Dr Howie McKibbon as CEO
- June 2023 Quarterly Activities Report and Appendix 4C
Later from Botanix Pharmaceuticals
- September 2023 Quarterly Activities Report and Appendix 4C
- Investor Presentation and Investor Meetings
- Botanix Placement Secures $13.5M to Fund Sofdra Launch Prep
- Successful Completion of $13.5m Institutional Placement
- FDA Confirms Approach to Sofdra NDA Resubmission
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals